Sign in
ATNT-11A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE
Journal article   Open access  Peer reviewed

ATNT-11A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE

Jiayi Huang, Jian Campian, Amit Gujar, David Tran, A. Craig Lockhart, Todd DeWees, Christina Tsien and Albert Kim
Neuro-oncology (Charlottesville, Va.), Vol.17(Suppl 5), pp.v12-v12
2015-11
PMCID: PMC4638533

Abstract

Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
url
https://doi.org/10.1093/neuonc/nov205.11View
Published (Version of record) Open

Metrics

14 Record Views

Details